Literature DB >> 29349500

Exogenous H2S switches cardiac energy substrate metabolism by regulating SIRT3 expression in db/db mice.

Yu Sun1, Zhiliang Tian2, Ning Liu1, Linxue Zhang1, Zhaopeng Gao1, Xiaojiao Sun1, Miao Yu1, Jichao Wu1, Fan Yang1, Yajun Zhao1, Huan Ren3, He Chen4, Dechao Zhao5, Yan Wang6, Shiyun Dong1, Changqing Xu1, Fanghao Lu7, Weihua Zhang8,9.   

Abstract

Hydrogen sulfide (H2S) is involved in diverse physiological functions, such as anti-hypertension, anti-proliferation, regulating ATP synthesis, and reactive oxygen species production. Sirtuin 3 (SIRT3) is a NAD + -dependent deacetylase that regulates mitochondrial energy metabolism. The role of H2S in energy metabolism in diabetic cardiomyopathy (DCM) may be related to regulate SIRT3 expression; however, this role remains to be elucidated. We hypothesized that exogenous H2S could switch cardiac energy metabolic substrate preference by lysine acetylation through promoting the expression of SIRT3 in cardiac tissue of db/db mice. Db/db mice, neonatal rat cardiomyocytes, and H9c2 cell line with the treatment of high glucose, oleate, and palmitate were used as animal and cellular models of type 2 diabetes. Using LC-MS/MS, we identified 76 proteins that increased acetylation, including 8 enzymes related to fatty acid β-oxidation and 7 enzymes of the tricarboxylic acid (TCA) cycle in the db/db mice hearts compared to those with the treatment of NaHS. Exogenous H2S restored the expression of NAMPT and the ratio of NAD+/NADH enhanced the expression and activity of SIRT3. As a result of activation of SIRT3, the acetylation level and activity of fatty acid β-oxidation enzyme LCAD and the acetylation of glucose oxidation enzymes PDH, IDH2, and CS were reduced which resulted in activation of PDH, IDH2, and CS. Our finding suggested that H2S induced a switch in cardiac energy substrate utilization from fatty acid β-oxidation to glucose oxidation in DCM through regulating SIRT3 pathway. KEY MESSAGES: H2S regulated the acetylation level and activities of enzymes in fatty acid oxidation and glucose oxidation in cardiac tissues of db/db mice. Exogenous H2S decreased mitochondrial acetylation level through upregulating the expression and activity of SIRT3 in vivo and in vitro. H2S induced a switch in cardiac energy substrate utilization from fatty acid oxidation to glucose.

Entities:  

Keywords:  Acetylation; Fatty acid β-oxidation; Glucose oxidation; Hydrogen sulfide (H2S); Surtuin 3

Mesh:

Substances:

Year:  2018        PMID: 29349500     DOI: 10.1007/s00109-017-1616-3

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  15 in total

1.  Hydrogen sulfide regulates muscle RING finger-1 protein S-sulfhydration at Cys44 to prevent cardiac structural damage in diabetic cardiomyopathy.

Authors:  Xiaojiao Sun; Dechao Zhao; Fangping Lu; Shuo Peng; Miao Yu; Ning Liu; Yu Sun; Haining Du; Bingzhu Wang; Jian Chen; Shiyun Dong; Fanghao Lu; Weihua Zhang
Journal:  Br J Pharmacol       Date:  2019-04-29       Impact factor: 8.739

2.  Exogenous H2S reduces the acetylation levels of mitochondrial respiratory enzymes via regulating the NAD+-SIRT3 pathway in cardiac tissues of db/db mice.

Authors:  Yu Sun; Zongyan Teng; Xiaojiao Sun; Linxue Zhang; Jian Chen; Bingzhu Wang; Fangping Lu; Ning Liu; Miao Yu; Shuo Peng; Yan Wang; Dechao Zhao; Yajun Zhao; Huan Ren; Zhongyi Cheng; Shiyun Dong; Fanghao Lu; Weihua Zhang
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-06-11       Impact factor: 4.310

3.  Hydrogen Sulfide Is a Novel Protector of the Retinal Glycocalyx and Endothelial Permeability Barrier.

Authors:  Claire L Allen; Katarzyna Wolanska; Naseeb K Malhi; Andrew V Benest; Mark E Wood; Winfried Amoaku; Roberta Torregrossa; Matthew Whiteman; David O Bates; Jacqueline L Whatmore
Journal:  Front Cell Dev Biol       Date:  2021-09-07

Review 4.  Hydrogen sulfide plays a potential alternative for the treatment of metabolic disorders of diabetic cardiomyopathy.

Authors:  Nian-Hua Deng; Wen Luo; Dan-Dan Gui; Bin-Jie Yan; Kun Zhou; Kai-Jiang Tian; Zhong Ren; Wen-Hao Xiong; Zhi-Sheng Jiang
Journal:  Mol Cell Biochem       Date:  2021-10-23       Impact factor: 3.396

5.  Exogenous hydrogen sulfide protects against high glucose-induced apoptosis and oxidative stress by inhibiting the STAT3/HIF-1α pathway in H9c2 cardiomyocytes.

Authors:  Jing Li; Yi-Qiang Yuan; Li Zhang; Hua Zhang; Shen-Wei Zhang; Yu Zhang; Xue-Xi Xuan; Ming-Jie Wang; Jin-Ying Zhang
Journal:  Exp Ther Med       Date:  2019-09-23       Impact factor: 2.447

Review 6.  Hydrogen Sulfide (H2S)-Releasing Compounds: Therapeutic Potential in Cardiovascular Diseases.

Authors:  Lei Zhang; Yanan Wang; Yi Li; Lingli Li; Suowen Xu; Xiaojun Feng; Sheng Liu
Journal:  Front Pharmacol       Date:  2018-09-21       Impact factor: 5.810

7.  Icariin Ameliorates Diabetic Cardiomyopathy Through Apelin/Sirt3 Signalling to Improve Mitochondrial Dysfunction.

Authors:  Tingjuan Ni; Na Lin; Xingxiao Huang; Wenqiang Lu; Zhenzhu Sun; Jie Zhang; Hui Lin; Jufang Chi; Hangyuan Guo
Journal:  Front Pharmacol       Date:  2020-03-19       Impact factor: 5.810

Review 8.  Hydrogen Sulfide as a Potential Alternative for the Treatment of Myocardial Fibrosis.

Authors:  Se Chan Kang; Eun-Hwa Sohn; Sung Ryul Lee
Journal:  Oxid Med Cell Longev       Date:  2020-01-23       Impact factor: 6.543

9.  Hydrogen Sulfide Protects against Paraquat-Induced Acute Liver Injury in Rats by Regulating Oxidative Stress, Mitochondrial Function, and Inflammation.

Authors:  Zhenning Liu; Xiaofeng Wang; Lei Li; Guigui Wei; Min Zhao
Journal:  Oxid Med Cell Longev       Date:  2020-01-23       Impact factor: 6.543

Review 10.  Mitochondrial Mechanisms in Diabetic Cardiomyopathy.

Authors:  Johannes Gollmer; Andreas Zirlik; Heiko Bugger
Journal:  Diabetes Metab J       Date:  2020-02       Impact factor: 5.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.